Inventors:
Brenda Cooperstone - Bryn Mawr PA, US
Robert Clare - Wayne PA, US
George Stanley - Surrey, GB
International Classification:
A61K031/4745
Abstract:
This invention provides the use of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) in the treatment or inhibition of hepatic fibrosis and hepatic cirrhosis.